IDEAYA Biosciences (IDYA) Stock Statistics & Valuation Metrics

IDEAYA Biosciences has a market cap or net worth of $2.59B. The enterprise value is $2.50B.

IDEAYA Biosciences has 87,814,026 shares outstanding. The number of shares has decreased by -2.65% in one year.

IDEAYA Biosciences’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -15.16%.

The current PE Ratio of IDEAYA Biosciences is ―. IDEAYA Biosciences’s PEG ratio is 0.43.

In the last 12 months, IDEAYA Biosciences had revenue of 218.71M and earned -113.70M in profits. Earnings per share was -1.28.

In the last 12 months, operating cash flow was -71.10M and capital expenditures -2.37M, giving a free cash flow of -73.47M billion.

IDEAYA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

IDEAYA Biosciences upcoming earnings date is May 12, 2026, After Close (Confirmed).

IDEAYA Biosciences as a current ratio of 11.34, with Debt / Equity ratio of 5.42%

In the past 12 months, IDEAYA Biosciences has paid 0.00 in taxes.

IDEAYA Biosciences EV to EBITDA ratio is -19.22, with an EV/FCF ratio of -40.48.

IDEAYA Biosciences has $639.39M in cash and marketable securities with $55.49M in debt, giving a net cash position of $583.90M billion.

Gross margin is 97.90%, with operating margin of -72.84%, and net profit margin of -51.99%.

The average price target for IDEAYA Biosciences is $56.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy